National Health Act 1953 Amendment special arrangements under subsection 100(1) Chemotherapy Pharmaceuticals Access Program (No. PB 19 of 2008) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 19 of 2008

Amendment special arrangements under subsection 100(1) of the National Health Act 1953

I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsection 100(1) of the National Health Act 1953.

Dated 2^nd January 2008

DIANA MACDONELL

Acting Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment Special Arrangements — Chemotherapy Pharmaceuticals Access Program

1              Commencement

This instrument commences on 1 February 2008.

2              Amendment of PB 93 of 2007

Schedule 1 amends PB 93 of 2007.

Schedule 1        Amendments

[1]           Schedule 1, item dealing with Pemetrexed

omit from the column headed “Circumstances” the words:

Pleural mesothelioma

and substitute:

Mesothelioma

[2]           Schedule 2, item dealing with Cetuximab

omit from the column headed “Maximum quantity”:

6

and substitute:

1

[3]           Schedule 3, item dealing with Cetuximab

omit from the column headed “Maximum quantity”:

4

and substitute:

1

[4]           Schedule 3, item dealing with Pemetrexed

omit from the column headed “Purposes” the words:

Pleural mesothelioma

and substitute:

Mesothelioma